Human erythrocyte-derived nanovesicles can readily be loaded with doxorubicin and act as anticancer agents.

JSON

Dubois L, None , Löf L, Larsson A, Hultenby K, Waldenström A, Kamali-Moghaddam M, Ronquist G, Ronquist KG

Cancer Res Front 4 (1) 13-26 [2018-04-20; online 2018-04-20]

Affinity Proteomics Uppsala [Technology development]

PLA and Single Cell Proteomics [Technology development]

DOI 10.17980/2018.13

Crossref 10.17980/2018.13